IGF-I prevents glutamate-induced motor neuron programmed cell death
Insulin-like growth factor I (IGF-I) is currently in clinical trials for treatment of amyotrophic lateral sclerosis (ALS), but little is known about how it promotes the survival of motor neurons. In the current study, we examined IGF-I-mediated neuroprotection in an in vitro model of ALS utilizing e...
Main Authors: | Andrea M Vincent, Bret C Mobley, Andrew Hiller, Eva L Feldman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2004-07-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996104000658 |
Similar Items
-
Increased motor neuron resilience by small molecule compounds that regulate IGF-II expression
by: Teresia M. Osborn, et al.
Published: (2018-02-01) -
Trophic activity of Rabies G protein-pseudotyped equine infectious anemia viral vector mediated IGF-I motor neuron gene transfer in vitro
by: Qingshan Teng, et al.
Published: (2005-12-01) -
Upper Motor Neuron Disorders: Primary Lateral Sclerosis, Upper Motor Neuron Dominant Amyotrophic Lateral Sclerosis, and Hereditary Spastic Paraplegia
by: Timothy Fullam, et al.
Published: (2021-05-01) -
Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS
by: Colin K. Franz, et al.
Published: (2009-03-01) -
Living with motor neurone disease: An interpretive study
by: Brott, Tamzin
Published: (2018)